Simon J. Allen joined our company as Chief Executive Officer in March 2016. From February 2015 to February 2016 he was a consultant to Solstice Biologics. Mr. Allen was the Chief Business Officer at Ambrx Inc. from September 2010 to January 2015 where he established collaborations with Bristol-Myers Squibb, Merck, Astellas, Eli Lilly, Zhejiang Medicine and Zhejiang Hisun Pharmaceutical that realized over $120M in non-dilutive funding and $1.5B in future milestones.
Prior to Ambrx, Mr. Allen was the CEO of Kalypsys Inc. from April 2008 to June 2010 and Chief Commercial Officer of CovX Inc. (acquired by Pfizer) from August 2006 to March 2008. Mr. Allen has held business development positions at companies such as Nuvelo, Inc., Skypharma PLC, and Corixa Corporation before working as a healthcare equities analyst at Burdett, Buckeridge & Young and a Research Biologist at Gilead Sciences.
Mr. Allen graduated from the University of Sydney with a B.Sc degree in Biochemistry and earned his MBA from the Australian Graduate School of Management.
Jon L. Stern joined CohBar in August 2012 and has served as Chief Executive Officer from October 2013 through March 2016. Beginning March 2016, Mr. Stern assumed the new role of Chief Operating Officer. He was appointed to our board of directors in May 2014.
From 2009 to 2011 Mr. Stern served as Chief Operating Officer of The Key Worldwide, a provider of college admissions preparation and coaching services for aspiring students and their families in the U.S. and Asia. From 2006 to 2008, Mr. Stern served as Executive Vice President of Integrated China Media, a Guangzhou, China-based provider of digital entertainment content for the Chinese youth market. From 2003 to 2008, Mr. Stern was a partner in Pacific Arts Group, a publisher and collection of Chinese Contemporary Fine Art. Mr. Stern founded Digital Sparx in 1999, a distributor of digital entertainment content to movie-goers and served as President and CEO of that company until 2002.
In 1986 Mr. Stern founded Cine Coasters, Inc., a developer and distributor of sports stadium and movie theatre products and accessories, and served as its Chief Executive Officer until its sale to a division of Liberty Media in 1998. Mr. Stern holds an MBA from the Marshall School of Business at the University of Southern California and a B.S. in Business Administration from The University of California, Berkeley.
Kenneth C. Cundy joined our company as Chief Scientific Officer in November 2014. From December 2012 to November 2014, Dr. Cundy served as the Chief Scientific Officer for XenoPort, Inc., a biopharmaceutical company focused on the development of product candidates for the potential treatment of neurological disorders. Dr. Cundy served XenoPort, Inc. as Senior Vice President of Preclinical and Clinical Sciences from 2011 to 2012, as its Vice President of Preclinical Development from 2004 to 2011, and as its Vice President of Biopharmaceutics from 2000 to 2004. From 1992 to 2000, Dr. Cundy was Senior Director of Biopharmaceutics at Gilead Sciences, Inc. Prior to Gilead Sciences, from 1988 to 1992, Dr. Cundy was Principal Research Investigator at Sterling Drug, a pharmaceutical division of Eastman Kodak Company.
Dr. Cundy received a B.S. in Pharmacy from the University of Manchester and was registered as a pharmacist in the UK. He received a Ph.D. in Pharmaceutical Sciences from the University of Kentucky and postdoctoral training in Biochemistry at the University of California, Berkeley.
Jeffrey F. Biunno joined our company in October 2013 as Chief Financial Officer and was appointed Secretary and Treasurer in September 2014. Prior to joining CohBar, Mr. Biunno served as Chief Financial Officer, Secretary and Treasurer of ManageIQ, Inc., a provider of global cloud IT systems management solutions, from March 2012 until its acquisition by Red Hat, Inc. in December 2012. From February 2009 until March 2012 Mr. Biunno served as Vice President and Worldwide Controller of Dialogic Inc., a provider of mobile telecommunications network software and hardware enterprise solutions then listed on NASDAQ.
Mr. Biunno founded Scalable Financial Solutions, LLC, a financial consulting firm, and operated it from March 2008 to January 2009. From February 2005 to March 2008, Mr. Biunno worked at Geller & Company, a financial services consulting firm. From 1997 to 2004 Mr. Biunno served as Vice President and Corporate Controller of Novadigm, Inc. (NASDAQ: NVDM), an international provider of IT systems management solutions to Fortune 500 companies and government agencies.
Mr. Biunno received a B.S. in Accounting and an MBA in Finance from Montclair State University. Mr. Biunno is a Certified Public Accountant and a Chartered Global Management Accountant.